ATAGI weighs up teen COVID-19 boosters
The advisory group is looking at Pfizer data on teens as kids' vaccinations pass a milestone
ATAGI is considering whether to approve COVID-19 boosters for 12 to 15-year-olds, as the country passes a milestone on vaccinating younger children.
A statement from the federal Department of Health says ATAGI is reviewing data on the use of the Pfizer vaccine for 12 to 15-year-olds as a booster.
